Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial Cancer-Reply.

Joaquim Bellmunt, Ronald de Wit, David J. Vaughn, Yves Fradet, Jae-Lyun Lee, Lawrence Fong, Nicholas J. Vogelzang, Miguel A. Climent, Daniel P. Petrylak, Toni K. Choueiri, Andrea Necchi, Winald Gerritsen, Howard Gurney, David I. Quinn, Stéphane Culine, Cora N. Sternberg, Yabing Mai, Christian H. Poehlein, Rodolfo F. Perini, Dean F. Bajorin, Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma The New England Journal of Medicine. ,vol. 376, pp. 1015- 1026 ,(2017) , 10.1056/NEJMOA1613683

Thomas Powles, Ignacio Durán, Michiel S van der Heijden, Yohann Loriot, Nicholas J Vogelzang, Ugo De Giorgi, Stéphane Oudard, Margitta M Retz, Daniel Castellano, Aristotelis Bamias, Aude Fléchon, Gwenaëlle Gravis, Syed Hussain, Toshimi Takano, Ning Leng, Edward E Kadel, Romain Banchereau, Priti S Hegde, Sanjeev Mariathasan, Na Cui, Xiaodong Shen, Christina L Derleth, Marjorie C Green, Alain Ravaud, Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial. The Lancet. ,vol. 391, pp. 748- 757 ,(2017) , 10.1016/S0140-6736(17)33297-X

Srikala S. Sridhar, Normand Blais, Ben Tran, M. Neil Reaume, Scott A. North, Martin R. Stockler, Kim N. Chi, Neil E. Fleshner, Geoffrey Liu, John W. Robinson, Som D. Mukherjee, Yasmin Rahim, Eric Winquist, Christopher M. Booth, Nghia Trung Nguyen, Emma K. Beardsley, Nimira S. Alimohamed, Gail T. McDonald, Keyue Ding, Wendy R. Parulekar, Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial JAMA Oncology. ,vol. 6, pp. 1751- 1758 ,(2020) , 10.1001/JAMAONCOL.2020.3927